Jeffrey A. Sloan

Jeffrey A. Sloan's AcademicInfluence.com Rankings

Jeffrey A. Sloan

Psychology

#2085

World Rank

#2442

Historical Rank

psychology Degrees

Download Badge

Psychology

Jeffrey A. Sloan's Degrees

PhD Psychology Stanford University
Masters Psychology Stanford University
Bachelors Psychology University of California, Berkeley

Similar Degrees You Can Earn

Best Online Bachelor's in Psychology 2025

Why Is Jeffrey A. Sloan Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Jeffrey A. Sloan's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Interpretation of Changes in Health-related Quality of Life: The Remarkable Universality of Half a Standard Deviation (2003) (3732)
Burnout and satisfaction with work-life balance among US physicians relative to the general US population. (2012) (2534)
Changes in Burnout and Satisfaction With Work-Life Balance in Physicians and the General US Working Population Between 2011 and 2014. (2015) (1988)
Recommended methods for determining responsiveness and minimally important differences for patient-reported outcomes. (2008) (1670)
Burnout and Medical Errors Among American Surgeons (2010) (1497)
Symptom Monitoring With Patient-Reported Outcomes During Routine Cancer Treatment: A Randomized Controlled Trial. (2016) (1320)
Association of perceived medical errors with resident distress and empathy: a prospective longitudinal study. (2006) (1298)
Burnout Among U.S. Medical Students, Residents, and Early Career Physicians Relative to the General U.S. Population (2014) (1284)
Information needs and decisional preferences in women with breast cancer. (1997) (1150)
Decision making during serious illness: what role do patients really want to play? (1992) (1044)
Patient engagement in research: a systematic review (2014) (1038)
Burnout and Suicidal Ideation among U.S. Medical Students (2008) (979)
Burnout and Career Satisfaction Among American Surgeons (2009) (952)
The Control Preferences Scale. (1997) (931)
Association of resident fatigue and distress with perceived medical errors. (2009) (844)
Relationship Between Clerical Burden and Characteristics of the Electronic Environment With Physician Burnout and Professional Satisfaction. (2016) (718)
The well-being of physicians. (2003) (715)
Validity and Reliability of the US National Cancer Institute's Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE). (2015) (703)
Development of the National Cancer Institute's patient-reported outcomes version of the common terminology criteria for adverse events (PRO-CTCAE). (2014) (677)
Special report: suicidal ideation among American surgeons. (2011) (606)
Intervention to promote physician well-being, job satisfaction, and professionalism: a randomized clinical trial. (2014) (571)
Personal Life Events and Medical Student Burnout: A Multicenter Study (2006) (548)
How Do Distress and Well-being Relate to Medical Student Empathy? A Multicenter Study (2007) (534)
Relationship between burnout and professional conduct and attitudes among US medical students. (2010) (524)
Single Item Measures of Emotional Exhaustion and Depersonalization Are Useful for Assessing Burnout in Medical Professionals (2009) (477)
Career fit and burnout among academic faculty. (2009) (476)
Impact of organizational leadership on physician burnout and satisfaction. (2015) (455)
Relationship between work-home conflicts and burnout among American surgeons: a comparison by sex. (2011) (447)
Recommendations on evidence needed to support measurement equivalence between electronic and paper-based patient-reported outcome (PRO) measures: ISPOR ePRO Good Research Practices Task Force report. (2009) (443)
Longitudinal Study Evaluating the Association Between Physician Burnout and Changes in Professional Work Effort. (2016) (426)
Physician satisfaction and burnout at different career stages. (2013) (421)
Recommendations for incorporating patient-reported outcomes into clinical comparative effectiveness research in adult oncology. (2012) (397)
Relationship between increased personal well-being and enhanced empathy among internal medicine residents (2005) (389)
Burnout and Serious Thoughts of Dropping Out of Medical School: A Multi-Institutional Study (2010) (387)
Responsiveness and minimal important differences for patient reported outcomes (2006) (383)
Safety and benefit of discontinuing statin therapy in the setting of advanced, life-limiting illness: a randomized clinical trial. (2015) (377)
Prevalence of alcohol use disorders among American surgeons. (2012) (368)
Concurrent Validity of Single-Item Measures of Emotional Exhaustion and Depersonalization in Burnout Assessment (2012) (364)
The learning environment and medical student burnout: a multicentre study (2009) (355)
The truly remarkable universality of half a standard deviation: confirmation through another look (2004) (353)
Symptom distress in newly diagnosed ambulatory cancer patients and as a predictor of survival in lung cancer. (1995) (328)
Impacting quality of life for patients with advanced cancer with a structured multidisciplinary intervention: a randomized controlled trial. (2006) (328)
Distress Among Matriculating Medical Students Relative to the General Population (2014) (300)
Race, ethnicity, and medical student well-being in the United States. (2007) (296)
Factors associated with resilience to and recovery from burnout: a prospective, multi‐institutional study of US medical students (2010) (294)
Treatment decision making in women newly diagnosed with breast cancer. (1996) (288)
The prevalence of substance use disorders in American physicians. (2015) (278)
Career Satisfaction, Practice Patterns and Burnout among Surgical Oncologists: Report on the Quality of Life of Members of the Society of Surgical Oncology (2007) (275)
Phase I trial of intraperitoneal administration of an oncolytic measles virus strain engineered to express carcinoembryonic antigen for recurrent ovarian cancer. (2010) (272)
Burnout and career satisfaction among US oncologists. (2014) (271)
A Phase I trial of the farnesyl transferase inhibitor SCH66336: evidence for biological and clinical activity. (2000) (270)
Clinical significance of patient-reported questionnaire data: another step toward consensus. (2005) (260)
Avoiding Burnout: The Personal Health Habits and Wellness Practices of US Surgeons (2012) (258)
Relationship between increased personal well-being and enhanced empathy among (2005) (257)
Retrospective review of 208 patients with leiomyosarcoma of the uterus: Prognostic indicators, surgical management, and adjuvant therapy (2003) (256)
Distress and Career Satisfaction Among 14 Surgical Specialties, Comparing Academic and Private Practice Settings (2011) (241)
Practical Guidelines for Assessing the Clinical Significance of Health-Related Quality of Life Changes within Clinical Trials (2003) (239)
Personal consequences of malpractice lawsuits on American surgeons. (2011) (237)
Randomized comparison of four tools measuring overall quality of life in patients with advanced cancer. (1998) (228)
Patterns of distress in US medical students (2011) (225)
Women experience greater toxicity with fluorouracil-based chemotherapy for colorectal cancer. (2002) (220)
The symptom burden of cancer: Evidence for a core set of cancer‐related and treatment‐related symptoms from the Eastern Cooperative Oncology Group Symptom Outcomes and Practice Patterns study (2013) (219)
The information needs of women newly diagnosed with breast cancer. (1995) (218)
Retrospective review of 208 patients with leiomyosarcoma of the uterus: prognostic indicators, surgical management, and adjuvant therapy. (2003) (217)
The relationship between cigarette smoking and quality of life after lung cancer diagnosis. (2004) (216)
Preferred roles in treatment decision making among patients with cancer: a pooled analysis of studies using the Control Preferences Scale. (2010) (213)
Assessing the clinical significance of single items relative to summated scores. (2002) (212)
Validation of single-item linear analog scale assessment of quality of life in neuro-oncology patients. (2007) (203)
A multicenter study of burnout, depression, and quality of life in minority and nonminority US medical students. (2006) (198)
The Impact of Stigma and Personal Experiences on the Help-Seeking Behaviors of Medical Students With Burnout (2015) (198)
A Prospective Study of Quality of Life in Adults with Newly Diagnosed High-grade Gliomas: The Impact of the Extent of Resection on Quality of Life and Survival (2005) (193)
The Myelofibrosis Symptom Assessment Form (MFSAF): an evidence-based brief inventory to measure quality of life and symptomatic response to treatment in myelofibrosis. (2009) (192)
Burnout, career satisfaction, and well-being among US neurologists in 2016 (2017) (183)
Dyspnea in cancer patients: prevalence and associated factors. (2001) (182)
Relationship of Pass/Fail Grading and Curriculum Structure With Well-Being Among Preclinical Medical Students: A Multi-Institutional Study (2011) (181)
Surgeon distress as calibrated by hours worked and nights on call. (2010) (170)
Prospective Study of Quality of Life in Adults with Newly Diagnosed High-grade Gliomas (2006) (170)
Assessing clinical significance in measuring oncology patient quality of life: introduction to the symposium, content overview, and definition of terms. (2002) (169)
Phase I–II trial of ONYX-015 in combination with MAP chemotherapy in patients with advanced sarcomas (2005) (166)
Patient-reported outcomes in randomized clinical trials: development of ISOQOL reporting standards (2012) (165)
Relationship between deficits in overall quality of life and non-small-cell lung cancer survival. (2012) (160)
Analysing data from patient-reported outcome and quality of life endpoints for cancer clinical trials: a start in setting international standards. (2016) (151)
The clinical significance of quality of life assessments in oncology: a summary for clinicians (2006) (148)
Phase 1 study of interleukin-12 in combination with rituximab in patients with B-cell non-Hodgkin lymphoma. (2002) (148)
The Well-Being and Personal Wellness Promotion Strategies of Medical Oncologists in the North Central Cancer Treatment Group (2005) (147)
PCN122 DEVELOPMENT OF THE PATIENT-REPORTED VERSION OF THE COMMON TERMINOLOGY CRITERIA FOR ADVERSE EVENTS (PRO-CTCAE) (2010) (147)
Regorafenib dose-optimisation in patients with refractory metastatic colorectal cancer (ReDOS): a randomised, multicentre, open-label, phase 2 study. (2019) (145)
Why do surgeons consider leaving practice? (2011) (145)
Assessing the Minimally Clinically Significant Difference: Scientific Considerations, Challenges and Solutions (2005) (144)
Quality of Life and Symptom Burden among Long-Term Lung Cancer Survivors (2012) (141)
Satisfaction with work-life balance and the career and retirement plans of US oncologists. (2014) (139)
Quality of Life Analysis of a Radiation Dose-Escalation Study of Patients With Non-Small-Cell Lung Cancer: A Secondary Analysis of the Radiation Therapy Oncology Group 0617 Randomized Clinical Trial. (2016) (135)
The Burden of Fatigue and Quality of Life in Myeloproliferative Disorders (MPDs): An International Internet Based Survey of 1179 MPD Patients. (2006) (131)
Complementary and alternative medicine use by patients enrolled onto phase I clinical trials. (2004) (131)
Utility of a Brief Screening Tool to Identify Physicians in Distress (2013) (129)
Aerosol granulocyte macrophage-colony stimulating factor: a low toxicity, lung-specific biological therapy in patients with lung metastases. (1999) (128)
Issues for Statisticians in Conducting Analyses and Translating Results for Quality of Life End Points in Clinical Trials (2004) (128)
Emotional Problems, Quality of Life, and Symptom Burden in Patients With Lung Cancer. (2017) (127)
A Multi-institutional Study Exploring the Impact of Positive Mental Health on Medical Students’ Professionalism in an Era of High Burnout (2012) (126)
Family Members’ Perceptions of Palliative Cancer Care: Predictors of Family Functioning and Family Members’ Health (1996) (124)
Perceptions of symptom distress in lung cancer patients: I. Congruence between patients and primary family caregivers. (1997) (124)
Quality of Life of Adults with Unhealed and Healed Diabetic Foot Ulcers (2006) (123)
Quality of life in chronic lymphocytic leukemia: an international survey of 1482 patients (2007) (121)
ASCPRO recommendations for the assessment of fatigue as an outcome in clinical trials. (2010) (119)
International standards for the analysis of quality-of-life and patient-reported outcome endpoints in cancer randomised controlled trials: recommendations of the SISAQOL Consortium. (2020) (118)
Development and Initial Testing of a New Socioeconomic Status Measure Based on Housing Data (2011) (116)
Mometasone furoate effect on acute skin toxicity in breast cancer patients receiving radiotherapy: a phase III double-blind, randomized trial from the North Central Cancer Treatment Group N06C4. (2011) (115)
Phase I and pharmacologic study of sequences of gemcitabine and the multitargeted antifolate agent in patients with advanced solid tumors. (2000) (113)
Challenges With Health‐related Quality of Life Assessment in Arthroplasty Patients: Problems and Solutions (2010) (110)
Work-home conflicts have a substantial impact on career decisions that affect the adequacy of the surgical workforce. (2012) (106)
Does zinc sulfate prevent therapy-induced taste alterations in head and neck cancer patients? Results of phase III double-blind, placebo-controlled trial from the North Central Cancer Treatment Group (N01C4). (2007) (103)
Phase I trial of dolastatin-10 (NSC 376128) in patients with advanced solid tumors. (1999) (99)
Common troublesome symptoms and their impact on quality of life in patients with myelodysplastic syndromes (MDS): results of a large internet-based survey. (2008) (97)
A Survey of U.S. Physicians and Their Partners Regarding the Impact of Work–Home Conflict (2013) (95)
Integrating patient-reported outcomes into cancer symptom management clinical trials supported by the National Cancer Institute-sponsored clinical trials networks. (2007) (94)
A nurse practitioner directed intervention improves the quality of life of patients with metastatic cancer: results of a randomized pilot study. (2012) (94)
Comparison of individual-level versus area-level socioeconomic measures in assessing health outcomes of children in Olmsted County, Minnesota (2013) (89)
An Interactive Individualized Intervention to Promote Behavioral Change to Increase Personal Well-Being in US Surgeons (2014) (88)
Work/Home conflict and burnout among academic internal medicine physicians. (2011) (87)
Interpreting and reporting results based on patient-reported outcomes. (2007) (86)
Caregiver role stress: when families become providers. (2007) (85)
Does marital status impact survival and quality of life in patients with non-small cell lung cancer? Observations from the mayo clinic lung cancer cohort. (2007) (82)
Assessing the clinical significance of single items relative to summated scores (2002) (82)
Development and preliminary psychometric properties of a well-being index for medical students (2010) (79)
Will Improvement in Quality of Life (QOL) Impact Fatigue in Patients Receiving Radiation Therapy for Advanced Cancer? (2006) (79)
A Stoma Quality of Life Scale (2006) (79)
Beyond maximum grade: modernising the assessment and reporting of adverse events in haematological malignancies. (2018) (78)
Ability of the physician well-being index to identify residents in distress. (2014) (78)
Assessing the Symptoms of Cancer Using Patient-Reported Outcomes (ASCPRO): searching for standards. (2010) (77)
Phase I dose-finding and pharmacokinetic trial of irinotecan hydrochloride (CPT-11) using a once-every-three-week dosing schedule for patients with advanced solid tumor malignancy. (2000) (77)
Motivational readiness for physical activity and quality of life in long-term lung cancer survivors. (2008) (75)
Comparison of frail patients versus nonfrail patients ≥65 years of age undergoing percutaneous coronary intervention. (2012) (75)
The value of a symptom cluster of fatigue, dyspnea, and cough in predicting clinical outcomes in lung cancer survivors. (2011) (75)
TAP1, TAP2, and HLA-DR2 alleles are predictors of cervical cancer risk. (2003) (74)
Efficacy of a Brief Screening Tool to Identify Medical Students in Distress (2011) (74)
Burnout, career satisfaction, and well-being among US neurology residents and fellows in 2016 (2017) (71)
Phase I study of the matrix metalloproteinase inhibitor, BAY 12-9566. (2001) (69)
Relationship between cytokine gene single nucleotide polymorphisms and symptom burden and quality of life in lung cancer survivors (2010) (69)
A simple stratification factor prognostic for survival in advanced cancer: the good/bad/uncertain index. (2001) (68)
Burnout and Career Satisfaction Among Surgical Oncologists Compared with Other Surgical Specialties (2010) (67)
Physical activity level and quality of life in long term lung cancer survivors. (2012) (65)
Long-Term Follow-Up and Individual Item Analysis of Quality of Life Assessments Related to Laparoscopic-Assisted Colectomy in the COST Trial 93-46-53 (INT 0146) (2011) (64)
Phase I and pharmacokinetic study of irinotecan and docetaxel in patients with advanced solid tumors: preliminary evidence of clinical activity. (2000) (64)
Symptom burden, quality of life, and attitudes toward palliative care in patients with pulmonary arterial hypertension: results from a cross-sectional patient survey. (2012) (63)
Phase 1 Trial of Flavopiridol Combined with Cisplatin or Carboplatin in Patients with Advanced Malignancies with the Assessment of Pharmacokinetic and Pharmacodynamic End Points (2005) (63)
Quality of Life of Caregivers of Patients With Advanced-Stage Cancer (2006) (62)
Sex differences in fluorouracil-induced stomatitis. (2000) (60)
Fatigue, dyspnea, and cough comprise a persistent symptom cluster up to five years after diagnosis with lung cancer. (2011) (59)
The Imperative for a New Approach to Toxicity Analysis in Oncology Clinical Trials. (2015) (59)
Biological pathways, candidate genes, and molecular markers associated with quality-of-life domains: an update (2014) (59)
Normative data and clinically significant effect sizes for single-item numerical linear analogue self-assessment (LASA) scales (2014) (58)
Cancer caregiver quality of life: need for targeted intervention (2016) (56)
Measuring spiritual quality of life in patients with cancer. (2007) (56)
A Prospective Study of the Relationship between Medical Knowledge and Professionalism among Internal Medicine Residents (2007) (56)
Pretreatment Quality of Life Is an Independent Prognostic Factor for Overall Survival in Patients with Advanced Stage Non-small Cell Lung Cancer (2009) (56)
Age and sex differences in burnout, career satisfaction, and well-being in US neurologists (2018) (55)
Complementary and alternative medicine use among long‐term lymphoma survivors: A pilot study (2009) (54)
The medical marriage: a national survey of the spouses/partners of US physicians. (2013) (53)
Incremental costs of enrolling cancer patients in clinical trials: a population-based study. (1999) (53)
Statistical analysis of patient-reported outcome data in randomised controlled trials of locally advanced and metastatic breast cancer: a systematic review. (2018) (53)
Role of a Medical Social Worker in Improving Quality of Life for Patients with Advanced Cancer with a Structured Multidisciplinary Intervention (2007) (53)
Relationship of Optimism–Pessimism and Health-Related Quality of Life in Breast Cancer Survivors (2008) (53)
Scientific imperatives, clinical implications, and theoretical underpinnings for the investigation of the relationship between genetic variables and patient-reported quality-of-life outcomes (2010) (52)
SNPs in PTGS2 and LTA predict pain and quality of life in long term lung cancer survivors. (2012) (51)
Harmonizing and consolidating the measurement of patient-reported information at health care institutions: a position statement of the Mayo Clinic (2014) (51)
The Establishment of the GENEQOL Consortium to Investigate the Genetic Disposition of Patient-Reported Quality-of-Life Outcomes (2009) (51)
Comparison of provider-assessed and patient-reported outcome measures of acute skin toxicity during a Phase III trial of mometasone cream versus placebo during breast radiotherapy: the North Central Cancer Treatment Group (N06C4). (2009) (51)
Evaluation of different recall periods for the US National Cancer Institute’s PRO-CTCAE (2017) (51)
Recommendations for including multiple symptoms as endpoints in cancer clinical trials (2013) (49)
Do age and quality of life of patients with cancer influence quality of life of the caregiver? (2014) (49)
Quality of life after breast cancer surgery: What have we learned and where should we go next? (2009) (48)
Quality of life in 650 lung cancer survivors 6 months to 4 years after diagnosis. (2004) (48)
Measuring outcomes in randomized prospective trials in palliative care. (2007) (48)
Impact of symptom burden on work-related abilities in patients with locally recurrent or metastatic breast cancer: Results from a substudy of the VIRGO observational cohort study. (2014) (48)
A phase I study of 153Sm-EDTMP with fixed high-dose melphalan as a peripheral blood stem cell conditioning regimen in patients with multiple myeloma (2005) (48)
Genetic determinants of lung cancer short-term survival: the role of glutathione-related genes. (2002) (47)
The problems program directors inherit: medical student distress at the time of graduation (2011) (47)
Oncology fellows’ career plans, expectations, and well-being: do fellows know what they are getting into? (2014) (47)
Composite grading algorithm for the National Cancer Institute’s Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE) (2020) (45)
Health related quality of life in patients with Charcot arthropathy of the foot and ankle. (2008) (45)
The Mayo Clinic manuscript series relative to the discussion, dissemination, and operationalization of the Food and Drug Administration guidance on patient-reported outcomes. (2007) (44)
Phase I and pharmacokinetic study of two different schedules of oxaliplatin, irinotecan, Fluorouracil, and leucovorin in patients with solid tumors. (2003) (44)
Analysis and interpretation of results based on patient-reported outcomes. (2007) (43)
The relation between cancer patient treatment decision‐making roles and quality of life (2013) (43)
A Brief Patient-Reported Outcomes Quality of Life (PROQOL) Instrument to Improve Patient Care (2013) (42)
Development and Validation of a Disease‐Specific Questionnaire to Assess Patient‐Reported Symptoms in Polycystic Liver Disease (2016) (40)
Regorafenib dose optimization study (ReDOS): Randomized phase II trial to evaluate dosing strategies for regorafenib in refractory metastatic colorectal cancer (mCRC)â€“An ACCRU Network study. (2018) (40)
Association of optimism-pessimism with quality of life in patients with head and neck and thyroid cancers. (2006) (40)
The physician-patient relationship and quality of life: lessons from chronic lymphocytic leukemia. (2009) (39)
Moving forward toward standardizing analysis of quality of life data in randomized cancer clinical trials (2018) (39)
Spiritual quality of life in advanced cancer patients receiving radiation therapy (2014) (37)
Six-month quality-of-life and functional status of acute respiratory distress syndrome survivors compared to patients at risk: a population-based study (2015) (37)
The hospice patient's primary caregiver. What is their quality of life? (2003) (37)
Higher comorbidity, poor functional status and higher health care utilization in veterans with prevalent total knee arthroplasty or total hip arthroplasty (2009) (36)
Building resiliency: a cross-sectional study examining relationships among health-related quality of life, well-being, and disaster preparedness (2014) (36)
Impact of self-reported physical activity and health promotion behaviors on lung cancer survivorship (2016) (36)
Randomized clinical trial of imiquimod: an adjunct to treating cervical dysplasia. (2012) (36)
Physician Attitudes toward Palliative Care for Patients with Pulmonary Arterial Hypertension: Results of a Cross-Sectional Survey (2014) (35)
Ethnicity, Socioeconomic Status, and Health Disparities in a Mixed Rural-Urban US Community-Olmsted County, Minnesota. (2016) (35)
Suicidal Ideation Among American Surgeons (2017) (35)
Normative data and clinically significant effect sizes for single-item numerical linear analogue self-assessment (LASA) scales. (2014) (34)
Concordance between Individual vs. Area-Level Socioeconomic Measures in an Urban Setting (2015) (33)
Caregivers of Patients With Cancer Fatigue (2014) (33)
Rising importance of patient-reported outcomes. (2006) (33)
A two-county comparison of the HOUSES index on predicting self-rated health (2010) (33)
Palliative care consultations in patients with cancer: a mayo clinic 5-year review. (2011) (33)
Therapy-Related Symptom Checklist Use During Treatments at a Cancer Center (2013) (32)
Asking the obvious questions regarding patient burden. (2002) (32)
The need for and characteristics of randomized, phase III trials to evaluate symptom management in patients with cancer. (2002) (32)
Application of a novel socioeconomic measure using individual housing data in asthma research: an exploratory study (2014) (31)
Improving Adherence to Cancer Treatment by Addressing Quality of Life in Patients With Advanced Gastrointestinal Cancers. (2015) (31)
Development of a staging system for chemotherapy‐induced stomatitis: Western Consortium for Cancer Nursing Research (1991) (31)
Quality of life III: translating the science of quality-of-life assessment into clinical practice-an example-driven approach for practicing clinicians and clinical researchers. (2003) (31)
Phase III, double-blind study of depot octreotide versus placebo in the prevention of acute diarrhea in patients receiving pelvic radiation therapy: results of North Central Cancer Treatment Group N00CA. (2008) (30)
Development of the patient-reported version of the common terminology criteria for adverse events (PRO-CTCAE). (2010) (30)
Genetics and the quality of life. (2006) (29)
Phase I Study of Interleukin-12 in combination with Rituximab in patients with B-cell non-Hodgkin lymphoma (2001) (29)
Quality of Life (QOL) Analysis of the Randomized Radiation (RT) Dose-Escalation NSCLC Trial (RTOG 0617): The Rest of the Story (2013) (28)
Spiritual well-being in lung cancer survivors (2013) (28)
A new scoring system for predicting survival in patients with non-small cell lung cancer (2015) (28)
Genetic variations and patient-reported quality of life among patients with lung cancer. (2012) (27)
Cancer Caregiver: Perceived Benefits of Technology. (2015) (27)
Phase I and Pharmacologic Study of Infusional Topotecan and Carboplatin in Relapsed and Refractory Acute Leukemia (2005) (26)
A comparison of simple single-item measures and the common toxicity criteria in detecting the onset of oxaliplatin-induced peripheral neuropathy in patients with colorectal cancer (2005) (26)
Healthy immigrant families: Participatory development and baseline characteristics of a community-based physical activity and nutrition intervention. (2016) (26)
Comparative analysis of acute toxicities and patient reported outcomes between intensity-modulated proton therapy (IMPT) and volumetric modulated arc therapy (VMAT) for the treatment of oropharyngeal cancer. (2020) (25)
Design considerations for efficient prostate cancer chemoprevention trials. (2001) (25)
A National Study of Medical Students’ Attitudes Toward Self-Prescribing and Responsibility to Report Impaired Colleagues (2015) (25)
Overview of the American Society for Radiation Oncology-National Institutes of Health-American Association of Physicists in Medicine Workshop 2015: Exploring Opportunities for Radiation Oncology in the Era of Big Data. (2016) (24)
Towards the prevention of acute lung injury: a population based cohort study protocol (2010) (24)
A Double-Blinded Randomized Trial to Compare the Effectiveness of Minimally Invasive Procedures Using Patient-Reported Outcomes. (2015) (24)
Multisite, Randomized Trial of Early Integrated Palliative and Oncology Care in Patients with Advanced Lung and Gastrointestinal Cancer: Alliance A221303. (2020) (24)
A patient-level meta-analytic investigation of the prognostic significance of baseline quality of life (QOL) for overall survival (OS) among 3,704 patients participating in 24 North Central Cancer Treatment Group (NCCTG) and Mayo Clinic Cancer Center (MC) oncology clinical trials (2008) (23)
A Pessimistic Explanatory Style Is Prognostic for Poor Lung Cancer Survival (2010) (23)
Health-related quality of life in veterans with prevalent total knee arthroplasty and total hip arthroplasty. (2008) (23)
Marital Status and Quality of Life in Patients with Esophageal Cancer or Barrett's Esophagus: The Mayo Clinic Esophageal Adenocarcinoma and Barrett’s Esophagus Registry Study (2010) (23)
A Phase II Study of Topical Ceramides for Cutaneous Breast Cancer (2003) (23)
Distress and empathy do not drive changes in specialty preference among US medical students (2012) (22)
Gender Differences in Physician Service Provision Using Medicare Claims Data (2017) (22)
Perceptions of Statin Discontinuation among Patients with Life-Limiting Illness. (2017) (22)
Effect of 24-hour mandatory vs on-demand critical care specialist presence on long-term survival and quality of life of critically ill patients in the intensive care unit of a teaching hospital. (2012) (22)
Phase I study of the duocarmycin semisynthetic derivative KW-2189 given daily for five days every six weeks. (1998) (22)
Patient-reported outcomes in studies of complementary and alternative medicine: problems, solutions, and future directions. (2011) (22)
The prevalence of substance use disorders in American physicians. (2014) (21)
Electronic patient-reported outcomes and toxicities during radiotherapy for head-and-neck cancer (2017) (21)
Preliminary evidence of relationship between genetic markers and oncology patient quality of life (QOL). (2004) (21)
Overall survival and self-reported fatigue in patients with esophageal cancer (2013) (21)
Patient-reported outcomes questionnaire compliance in Cancer Cooperative Group Trials (Alliance N0992) (2016) (20)
Qualitative and quantitative analysis of women’s perceptions of transvaginal surgery (2012) (20)
Patient-reported distress and survival among patients receiving definitive radiation therapy (2017) (20)
Physician perspective on incorporation of oncology patient quality-of-life, fatigue, and pain assessment into clinical practice. (2014) (20)
Lessons From Large-Scale Collection of Patient-Reported Outcomes: Implications for Big Data Aggregation and Analytics. (2016) (20)
Psychometric Testing of the European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire–Chemotherapy-Induced Peripheral Neuropathy 20-Item Scale Using Pooled Chemotherapy-Induced Peripheral Neuropathy Outcome Measures Standardization and Alliance for Clinical Trials in O (2019) (20)
Evaluation of Glutathione Metabolic Genes on Outcomes in Advanced Non-small Cell Lung Cancer Patients after Initial Treatment with Platinum-Based Chemotherapy: An NCCTG-97-24-51 Based Study (2009) (19)
Associations between Plasma Insulin-Like Growth Factor Proteins and C-Peptide and Quality of Life in Patients with Metastatic Colorectal Cancer (2005) (19)
A quality-adjusted reanalysis of a Phase III trial comparing once-daily thoracic radiation vs. twice-daily thoracic radiation in patients with limited-stage small-cell lung cancer(1). (2002) (18)
Outcomes of a Dignity Therapy/Life Plan Intervention for Patients With Advanced Cancer Undergoing Chemotherapy (2018) (18)
Is the use of QOL data really any different than other medical testing? (2006) (18)
Clinician vs Patient Reporting of Baseline and Postbaseline Symptoms for Adverse Event Assessment in Cancer Clinical Trials. (2019) (18)
Perioperative Patient-Reported Outcomes Predict Serious Postoperative Complications: a Secondary Analysis of the COST Trial (2014) (18)
Using the Skindex-16 and Common Terminology Criteria for Adverse Events to assess rash symptoms: results of a pooled-analysis (N0993) (2012) (18)
Prepared for what? addressing the disaster readiness gap beyond preparedness for survival (2015) (18)
A pilot study assessing social support among cancer patients enrolled on clinical trials: a comparison of younger versus older adults (2010) (17)
Acupuncture for treatment of noncyclic breast pain: a pilot study. (2011) (17)
Cytokine Profile Changes In 309 Myelofibrosis Patients: Comparison Of JAK1/JAK2 Inhibitor Therapy Vs. Placebo – Correlative Analysis From The Comfort-I Trial (2013) (17)
Patients with reconstruction of craniofacial or intraoral defects: development of instruments to measure quality of life. (2001) (17)
Hematology patient reported symptom screen to assess quality of life for AL amyloidosis (2017) (16)
Impact of vaginal dehydroepiandosterone (DHEA) on vaginal symptoms in female cancer survivors: Trial N10C1 (Alliance). (2014) (16)
Improving attribution of adverse events in oncology clinical trials. (2019) (16)
Spirituality and Emotional Distress Among Lung Cancer Survivors. (2019) (15)
Individualized decision aid for diverse women with lupus nephritis (IDEA-WON): A randomized controlled trial (2019) (15)
Quality of Life endpoints in prostate chemoprevention trials. (2001) (15)
The effect of disease severity markers on quality of life in autosomal dominant polycystic kidney disease: a systematic review, meta-analysis and meta-regression (2017) (14)
N08C9 (Alliance): A Phase 3 Randomized Study of Sulfasalazine Versus Placebo in the Prevention of Acute Diarrhea in Patients Receiving Pelvic Radiation Therapy. (2013) (14)
The Complementary Nature of Patient-Reported Outcomes and Adverse Event Reporting in Cooperative Group Oncology Clinical Trials: A Pooled Analysis (NCCTG N0591). (2015) (14)
Validity and reliability of the patient-reported outcomes version of the common terminology criteria for adverse events (PRO-CTCAE). (2012) (14)
Early intervention of patients at risk for acute respiratory failure and prolonged mechanical ventilation with a checklist aimed at the prevention of organ failure: protocol for a pragmatic stepped-wedged cluster trial of PROOFCheck (2016) (14)
Parental satisfaction of U.S. physicians: associated factors and comparison with the general U.S. working population (2016) (14)
Feasibility and Acceptability of a Dignity Therapy/Life Plan Intervention for Patients With Advanced Cancer. (2017) (13)
Using ePrognosis to estimate 2-year all-cause mortality in older women with breast cancer: Cancer and Leukemia Group B (CALGB) 49907 and 369901 (Alliance A151503) (2017) (13)
Risk of acute myeloid leukemia and myelodysplastic syndrome among older women receiving anthracycline-based adjuvant chemotherapy for breast cancer on Modern Cooperative Group Trials (Alliance A151511) (2016) (13)
Health behaviors and quality of life predictors for risk of hospitalization in an electronic health record-linked biobank (2015) (13)
Assessment of patient-reported measures of bowel function before and after pelvic radiotherapy: an ancillary study of the North Central Cancer Treatment Group study N00CA (2013) (13)
A phase I study of sequential irinotecan and 5-fluorouracil/leucovorin. (2002) (12)
Assessment of quality of life outcomes in the treatment of advanced colorectal malignancies. (2006) (11)
A new graphic for quality adjusted life years (Q-TWiST) survival analysis: The Q-TWiST plot (2002) (11)
Sample size and design considerations for phase II clinical trials with correlated observations. (1997) (11)
Practical and philosophical issues surrounding a national item bank: if we build it will they come? (2007) (11)
Assessing health disparities in children using a modified housing-related socioeconomic status measure: a cross-sectional study (2016) (11)
A randomized study to prevent lymphedema in women treated for breast cancer: CALGB 70305 (Alliance) (2020) (11)
Metrics to assess quality of life after management of early-stage lung cancer. (2011) (10)
Training Mid-level Providers on Palliative Care (2013) (10)
Intergroup Randomized Phase III Study of Postoperative Oxaliplatin, 5-Fluorouracil, and Leucovorin Versus Oxaliplatin, 5-Fluorouracil, Leucovorin, and Bevacizumab for Patients with Stage II or III Rectal Cancer Receiving Preoperative Chemoradiation: A Trial of the ECOG-ACRIN Research Group (E5204). (2019) (10)
An exploratory pilot study of palliative medicine compared to anesthesia-pain consultation for pain in patients with cancer. (2011) (10)
Is it simple or simplistic? (2003) (10)
Redesigning nighttime care for personal care residents. (2001) (10)
Overview and Introduction (2005) (10)
PROMIS for Laparoscopy (2015) (9)
Application of therapeutic harp sounds for quality of life among hospitalized patients. (2015) (9)
How much time do we have? Longitudinal perception of prognosis in newly-diagnosed high grade glioma patients and caregivers compared to clinicians (2021) (9)
Establishing a common metric for patient-reported outcomes in cancer patients: linking patient reported outcomes measurement information system (PROMIS), numerical rating scale, and patient-reported outcomes version of the common terminology criteria for adverse events (PRO-CTCAE) (2020) (9)
A pilot study of the patient-reported outcomes version of the common terminology criteria for adverse events (PRO-CTCAE) in a phase I clinical trial. (2013) (8)
Electronic Geriatric Assessment: Is It Feasible in a Multi-Institutional Study That Included a Notable Proportion of Older African American Patients? (Alliance A171603). (2021) (8)
Burnout and Quality of Life among Healthcare Research Faculty. (2015) (8)
Phase I trial of gemcitabine and CPT-11 given weekly for four weeks every six weeks. (2001) (8)
Validation study of the patient-reported outcomes version of the common terminology criteria for adverse events (PRO-CTCAE). (2010) (8)
Facebook: can it be a diagnostic tool for neurologists? (2012) (8)
Impact of a structured multidisciplinary intervention on quality of life of older adults with advanced cancer (2013) (8)
Conducting Cancer Control and Survivorship Research via Cooperative Groups: A Report from the American Society of Preventive Oncology (2011) (8)
Intervention to Promote PhysicianWell-being , Job Satisfaction , and Professionalism A Randomized Clinical Trial (2014) (8)
The comparative effectiveness of decision aids in diverse populations with early stage prostate cancer: a study protocol for a cluster-randomized controlled trial in the NCI Community Oncology Research Program (NCORP), Alliance A191402CD (2018) (7)
Patient-reported outcomes, emoji, and activity measured on the Apple Watch in cancer patients. (2018) (7)
Prognostic significance of baseline fatigue for overall survival: A patient-level meta-analysis of 43 oncology clinical trials with 3915 patients. (2017) (7)
Phase I trial of Intraperitoneal (IP) administration of a measles virus (MV) derivative expressing the human carcinoembryonic antigen (CEA) in recurrent ovarian cancer (OvCa) (2008) (7)
Symptom relief and quality of life after combined partial hepatectomy and cyst fenestration in highly symptomatic polycystic liver disease. (2020) (7)
Assessing the clinical significance of quality of life measures in oncology research: state of the science. Rochester, Minnesota, USA. April 5-6, 2002. Abstracts. (2002) (7)
Applying Rasch analysis to evaluate measurement equivalence of different administration formats of the Activity Limitation scale of the Cambridge Pulmonary Hypertension Outcome Review (CAMPHOR) (2016) (7)
Genetics and quality of life. (2006) (7)
Patient-Reported Outcomes after Laparoscopic Ventral Hernia Repair (2016) (7)
Meeting on the FDA draft guidance on patient-reported outcomes. (2007) (7)
Design and Analysis of Equivalence Clinical Trials Via the SAS ® System (1998) (6)
Intellectual Equipoise and Challenges: Accruing Patients With Advanced Cancer to a Trial Randomizing to Surgical or Nonsurgical Management (SWOG S1316) (2020) (6)
Health‐related quality of life outcomes for the LEAP study—CALGB 70305 (Alliance): A lymphedema prevention intervention trial for newly diagnosed breast cancer patients (2020) (6)
North Central Cancer Treatment Group--achievements and perspectives. (2008) (6)
Phase I trial of sequential administration of raltitrexed (Tomudex) and 5-iodo-2'-deoxyuridine (IdUrd). (2001) (6)
Patient satisfaction with participation in phase II/III NCCTG clinical trials: Was it worth it? (N0392). (2012) (6)
Does gender influence outcomes from a multidisciplinary intervention for quality of life designed for patients with advanced cancer? (2013) (6)
Responsiveness of quality of life instruments for the comparison of minimally invasive cholecystectomy procedures (2013) (6)
Phase I and pharmacological trial of fazarabine (Ara-AC) with granulocyte colony-stimulating factor. (1997) (6)
Comparing and Validating Simple Measures of Patient-Reported Peripheral Neuropathy for Oncology Clinical Trials: NCCTG N0897 (Alliance) A Pooled Analysis of 2440 Patients. (2015) (6)
Development of novel emoji scale to measure patient-reported outcomes in cancer patients. (2018) (5)
A patient-level pooled analysis of the prognostic significance of baseline fatigue for overall survival (OS) among 3,915 patients participating in 43 North Central Cancer Treatment Group (NCCTG) and Mayo Clinic Cancer Center (MC) oncology clinical trials. (2016) (5)
Combining survival and toxicity effect sizes from clinical trials into an interpretable, quality-adjusted survival effect size estimate of treatment efficacy. (2014) (5)
Reply to M. Aapro et al (2011) (5)
Quality of life (QOL) among patients (pts) with HER2+ breast cancer (bc) treated with adjuvant lapatinib and/or trastuzumab in the ALTTO study (BIG 2-06, Alliance N063D). (2014) (5)
Outcomes Assessment in Cancer: Statistical issues in the application of cancer outcome measures (2004) (5)
Prevention of lymphedema in women with breast cancer (BC): Results of CALGB (Alliance) 70305. (2017) (4)
Assessing the clinical significance of real-time quality of life (QOL) data in cancer patients treated with radiation therapy. (2010) (4)
Quality-of-life meta-analysis: why treat it differently? (2003) (4)
Dignity Therapy Feasibility for Cancer Patients Undergoing Chemotherapy (S734) (2016) (4)
Phase I trial of intraperitoneal (IP) administration of a measles virus (MV) derivative expressing the human carcinoembryonic antigen (CEA) in ovarian cancer patients. (2006) (4)
UEG Week 2016 Poster Presentations (2016) (4)
Validation of single item Linear Analogue Scale Assessments (LASAs) for assessing quality of life (QOL) in patients with newly diagnosed high-grade gliomas. (2006) (3)
Prospective longitudinal cohort study of patient recovery after major gastrointestinal surgery: is there a difference between minimally invasive and open approaches? (2019) (3)
Comparing and validating simple measures of patient-reported peripheral neuropathy (PRPN) for NCCTG Clinical Trials: A pooled analysis of 2,440 patients (pts) (2008) (3)
Osteoporosis health beliefs among postmenopausal women with a history of distal forearm fracture (2002) (3)
Assessment and Monitoring of Constitutional Symptoms in Patients with Myelofibrosis: A Proposed New Instrument the Myelofibrosis Symptom Assessment Form (MFSAF). (2008) (3)
Expanding beyond maximum grade: Chemotherapy toxicity over time by age and performance status in advanced non-small cell lung cancer in CALGB 9730 (Alliance A151729). (2020) (3)
Is There a Connection Between High Educational Debt and Suicidal Ideation Among Medical Students (2009) (3)
Quality of Life: The Assessment, Analysis, and Interpretation of Patient-Reported Outcomes by FAYERS, P. M. and MACHIN, D (2008) (3)
[Perception of symptom distress in lung cancer patients: I. Agreement between patients and their caregiving relatives]. (1999) (3)
Breaking bad news in cancer : an assessment of Maltese patients’ preferences (2017) (3)
Challenges in QOL assessment. Overview and introduction. (2005) (3)
Stoma location and ostomy-related quality of life among cancer survivors with ostomies: A pooled analysis. (2021) (3)
A Case Management System for Integrating Patient-reported Outcome Assessment in Clinical Practice: The Beacon Tool (2019) (3)
Patient-reported outcomes (PRO) in patients with metastatic breast cancer (MBC) from the VIRGO observational cohort study (OCS). (2012) (3)
Capturing breast cancer patients' experience beyond disease progression: Implementation of a patient-reported outcome (PRO) substudy in the VIRGO Metastatic Breast Cancer Observational Cohort study. (2010) (3)
Can complementary and alternative medicine clinical cancer research be successfully accomplished? The Mayo Clinic-North Central Cancer Treatment Group experience. (2006) (3)
Baseline quality of life (QOL) as a prognostic factor for overall survival (OS) in patients (Pts) with advanced stage non-small cell lung cancer (A-NSCLC): An analysis of NCCTG studies (2008) (3)
ANALYZING ONCOLOGY PATIENT HEALTH CARE COSTS USING THE SAS SYSTEM (1999) (2)
Patient quality of life: vitally important. (2014) (2)
How much missing data is too much? A single study exploration. (2006) (2)
2367 : Does Zinc Sulfate To Prevent Radiation-Induced Taste Alterations (“Dysgeusia”) in Head and Neck Cancer Patients? A North Central Cancer Treatment Group (NCCTG) Placebo-Controlled Trial (N01C4) (2006) (2)
Complementary and Alternative Medicine Use among Long-Term Survivors: A Pilot Study (2011) (2)
Cancer treatment impact on cognitive functioning and quality of life in lung cancer survivors. (2010) (2)
The feasibility of individualized prehabilitation for patients undergoing gastrointestinal cancer resections: a pilot study. (2019) (2)
Relationship between genetic markers and quality of life (QOL) in stage III colon cancer (CC) patients (pts) prior to adjuvant treatment (N0147). (2012) (2)
Effects of a lymphedema prevention intervention on range of motion among women receiving lymph node dissection for breast cancer treatment (Alliance) CALGB 70305. (2018) (2)
QOLP-07. A PILOT STUDY TO ASSESS THE INTEGRATION OF A UNIQUE PROQOL TOOL AND EARLY PALLIATIVE CARE INTERVENTION IN THE CARE OF HIGH GRADE GLIOMA PATIENTS AND THEIR CAREGIVERS (2019) (2)
Prospective evaluation of a 12-gene assay on patient treatment decisions and physician confidence in mismatch repair-proficient (MMR-P) stage IIa colon cancer patients. (2014) (2)
Characteristics of long-term lung cancer survivors. (2006) (2)
Pr6 Longitudinal evaluation of quality of life in long-term lung cancersurvivors (2005) (2)
What are patients’ biggest concerns? A patient reported outcome case-management system. (2017) (2)
Proceedings of Patient Reported Outcome Measures (PROMs) Conference Birmingham 2018 (2018) (2)
Composite grading algorithm for National Cancer Institute’s PRO-CTCAE. (2020) (2)
Identifying meaningful change on PROMIS short forms in cancer patients: a comparison of item response theory and classic test theory frameworks (2022) (2)
Patient-reported quality-of-life outcomes in relation to provider-assessed adverse events during head and neck radiotherapy (2020) (2)
Genetic variations underlying self-reported physical functioning: a review (2015) (2)
Relationships among quality of life and survival in anemic patients with advanced cancer undergoing chemotherapy (2005) (2)
Complementary and alternative medicine (CAM) use by patients enrolled in phase I clinical trials (2004) (2)
Comparison between clinician- and patient-reporting of baseline (BL) and post-BL symptomatic toxicities in cancer cooperative group clinical trials (NCCTG N0591 [Alliance]). (2015) (2)
60 Patient and Clinician Perceptions of Palliative Care in Pulmonary Arterial Hypertension (2012) (2)
Using the Skindex-16 and CTCAE to assess rash symptoms: Results of a pooled-analysis (N0993). (2010) (2)
Impact of Massage Therapy on the Quality of Life of Hospice Patients and Their Caregivers: A Pilot Study (2020) (2)
P123 Common troublesome symptoms and their impact on health-related quality of life (QoL) in 359 patients with myelodysplastic syndromes (MDS): results of an internet-based survey (2007) (2)
What is the value added of patient reported outcomes relative to physician rated symptom assessments? (2006) (1)
Use of baseline quality of life (QOL) as compared with performance status (PS) as prognostic factors for overall survival (OS) in patients with metastatic colorectal cancer (mCRC) (2008) (1)
Author response: Burnout, career satisfaction, and well-being among US neurology residents and fellows in 2016 (2018) (1)
Clustering of EORTC QLQ-C30 health-related quality of life scales across several cancer types: Validation study. (2022) (1)
Methodological Issues Regarding Cancer Anorexia/Cachexia Trials (2011) (1)
Calculating the net clinical benefit in neuro-oncology clinical trials using two methods: quality-adjusted survival effect sizes and joint modeling (2020) (1)
The value of concurrent symptoms in predicting clinical outcomes in lung cancer survivors. (2010) (1)
UvA-DARE (Digital Academic Repository) Scientific imperatives, clinical implications, and theoretical underpinnings for the investigation of the relationship between genetic variables and patient-reported quality-of-life outcomes Sprangers, (2010) (1)
Genetic disposition of quality of life (2014) (1)
Setting International Standards in Analyzing Patient-Reported Outcomes and Quality of Life Endpoints Data for Cancer Clinical Trials (2016) (1)
Phase 1 Oncology Clinical Trials for Related Subpopulations: The Power Walk Design* (2002) (1)
Resident Fatigue, Distress, and Medical Errors—Reply (2010) (1)
Primary and Secondary Endpoint Analysis of N08C9 (Alliance): A Phase 3 Randomized Trial of Sulfasalazine Versus Placebo in the Prevention of Acute Radiation Enteritis (2014) (1)
Linear Analog Scale Assessment (2014) (1)
Quality of Life Concerns of Long-Term Lymphoma Survivors: Results of a Pilot Study. (2005) (1)
Does cigarette smoking have an impact on quality of life after diagnosis of lung cancer (2003) (1)
Providing end-of-life care to patients seeking hope for cure: Improving Mayo Clinic palliative care utilization. (2006) (1)
Tumor burden is not related to quality of life in patients with metastatic colorectal cancer (2008) (1)
A new method to analyze adverse events longitudinally in oncology clinical trials. (2014) (1)
A comparison of simple single-item measures and the NCI Common Toxicity Criteria version 3.0 measure of peripheral neuropathy. (2012) (1)
QLIF-08. DETERMINING THE NET CLINICAL BENEFIT IN NEURO-ONCOLOGY CLINICAL TRIALS BY COMBINING SURVIVAL AND TOXICITY DATA (2017) (1)
Assessing Measurement Equivalence of Different Forms of Administration of the Cambridge Pulmonary Hypertension Outcome Review (CAMPHOR) Using Rasch Analysis (2013) (1)
Author response: Age and sex differences in burnout, career satisfaction, and well-being in US neurologists (2019) (1)
Burnout and career satisfaction among U.S. oncologists: Results of the 2012 ASCO survey. (2013) (1)
Feasibility of individualized prehabilitation for gastrointestinal cancer patients (2015) (1)
Medical Student Burnout and Professionalism—Reply (2011) (1)
The costs of incorporating quality-of-life assessments into clinical practice and research: What resources are required? (2003) (1)
A multicenter analysis of patient reported risk factors for not working during cancer therapy. (2017) (1)
15. Clinical Significance (2014) (1)
Breaking Bad News in Cancer (2017) (1)
Impact of hospital hospitality house programs on quality of life and mood of patients and caregivers after hematopoietic stem cell transplant. (2019) (1)
American ginseng (Panax quinquefolius) administration does not affect performance of the Roche COBAS Ampliprep/Taqman HIV-1 RNA assay (2014) (1)
Fatigue, the Un-Addressed Curse of Myeloproliferative Diseases (MPD): Results of an International Internet Based QOL Survey of 830 MPD Patients. (2005) (1)
QOLP-15. LONGITUDINAL PERCEPTION OF PROGNOSIS OF PATIENTS WITH HIGH GRADE GLIOMA COMPARED TO THEIR CAREGIVERS AND CLINICIANS (2019) (1)
The Physician-Patient Relationship Impacts Patient Quality of Life in Chronic Lymphocytic Leukemia: Results of an International Survey of 1482 Patients. (2007) (1)
Effects of patient-reported outcome assessment order (2022) (1)
Adverse event development in clinical oncology trials - Authors' reply. (2016) (1)
Resident Fatigue, Distress, and Medical Errors. Authors' reply (2010) (1)
Does gabapentin prevent delayed chemotherapy-induced nausea and vomiting (N/V)? Results of a randomized placebo controlled trial, NCCTG N08C3 (Alliance). (2013) (1)
Abstract P2-14-10: Self Reported Cognitive Function in Breast Cancer Survivors: A 12 Month Longitudinal Descriptive Study (2010) (1)
Treatment Trade-Offs in Myeloma: a Survey of Consecutive Patients (2012) (1)
What role do cancer patients want to play in treatment decision making: A pooled-analysis. (2006) (1)
Health and quality of life (QOL) issues in four groups of lung cancer patients: Low-dose computed tomography (LDCT) screened, chest x-ray detected, incidentally found, and routinely diagnosed. (2012) (0)
Evaluating Outcomes of Blepharoptosis Surgery through Validated Response Measures (2012) (0)
Analysis of overall survival and self-reported fatigue in patients with locally advanced esophageal cancer: A Mayo Clinic Esophageal Adenocarcinoma and Barrett's Esophagus Registry Consortium study. (2011) (0)
A pooled analysis of demographic characteristics and clinical outcomes of phase I oncology clinical trials, the Mayo Clinic experience. (2004) (0)
243 VETERANS WITH TOTAL KNEE ARTHRPLASTY (TKA) AND TOTAL HIP ARTHROPLASTY (THA) HAVE SIGNIFICANT FUNCTIONAL LIMITATION AND INCREASED HEALTH CARE UTILIZATION: A POPULATION BASED STUDY (2007) (0)
WE-B-201-02: Statistical Failings That Can Keep Us All in the Dark. (2016) (0)
Data from: Age and sex differences in burnout, career satisfaction, and well-being in US neurologists (2018) (0)
Physician Well-Being Index (2019) (0)
Pre-Emptive Versus Reactive Topical Clobetasol for Regorafenib-Induced Hand-Foot Reactions: A Preplanned Analysis of the ReDOS Trial. (2021) (0)
Erratum to: Genetic variations underlying self-reported physical functioning: a review (2014) (0)
Long-Term Survival, Functional Status And Quality-Adjusted Survival Of Patients With Acute Respiratory Failure - A Population-Based Study (2011) (0)
Feasibility of a Patient-Reported Outcomes Quality of Life Instrument to Improve Care in Underserved, Ethnic Minority Cancer Patients (2019) (0)
THU0651 AN INDIVIDUALIZED DECISION-AID FOR DIVERSE WOMEN WITH LUPUS NEPHRITIS (IDEA-WON): A RANDOMIZED CONTROLLED TRIAL (2019) (0)
6111 Calcium/magnesium (CaMg) reduces grade 2+ oxaliplatin-induced neurotoxicity in patients with glutathione S-transferase pi 1 (GSTP1) I105V polymorphism (2009) (0)
Compliance issues in completion of patient-reported outcomes in a series of NCCTG/Mayo clinical trials (2008) (0)
A dynamic managed care platform for palliative care. (2017) (0)
Health and Quality of Life Outcomes Responsiveness and minimal important differences for patient reported outcomes (2006) (0)
Scoring system predicting overall survival (OS) in patients (Pts) with non-small cell lung cancer (NSCLC). (2013) (0)
Patient assessment of measures of bowel function during and after pelvic radiation therapy: An ancillary study of North Central Cancer Treatment Group study N00CA. (2012) (0)
Association between patient perception of oncology clinical trial participation and survival: N0392 (Alliance). (2016) (0)
Genetic Influences on Quality of Life (2021) (0)
QOL and Survival Comparisons by Race in Oncology Clinical Trials. (2016) (0)
Body mass index (BMI) and physical activity in long-term lymphoma survivors: A pilot study. (2006) (0)
Baseline quality of life as a prognostic factor for overall survival in lung cancer patients. (2009) (0)
Is There a Connection Between High Educational Debt and Suicidal Ideation Among Medical Students? Authors' reply (2009) (0)
urgeon Distress as Calibrated by Hours Worked nd Nights on Call (0)
Patient-reported outcome driven case management system for hematology and oncology patients. (2016) (0)
OS7.4 Calculating the net clinical benefit in brain tumor clinical trials by combining survival and health-related quality of life data using two methods: quality adjusted survival effect sizes (QASES) and joint modelling (JM) (2019) (0)
Prostate cancer patients with Maspin-negative tumors can live over a decade § (2004) (0)
Overall survival and clinically deficient quality of life in patients with esophageal cancer or Barrett's esophagus: A Mayo Clinic Esophageal Adenocarcinoma and Barrett's Esophagus Registry Consortium study. (2010) (0)
Initial Quality-of-Life Deficit in Patient-Reported Outcome Is Related to Cancer Stage: A Single Institution Esophageal Adenocarcinoma Registry Study (2013) (0)
Real-Time Assessment of Patient-Reported Outcomes in Head-and-Neck Cancer Patients Undergoing Radiation Therapy (2013) (0)
Evaluating a Telehealth Program for Ostomy Self-Care among Cancer Survivors (2022) (0)
Modeling accrual of older adults to cancer clinical trials: (Alliance A151736). (2019) (0)
Association between Patient-Reported Outcomes and Physical Activity Measured on the Apple Watch in Patients with Hematological Malignancies (2017) (0)
Complementary and alternative medicine (CAM) use by patients enrolled in phase I clinical trials. (2004) (0)
PROMIS for Laparoscopy: A Pilot Study (2012) (0)
506 Peri-Operative Patient Reported Outcomes Predict Serious Surgical Complications (2014) (0)
Development of a Graves Ophthalmopathy Health–Related Quality of Life Instrument: Identification of Content Area Using Focus Groups (2006) (0)
P325 Feasibility and Acceptability of a Dignity Therapy/Life Plan Intervention for Individuals with Advanced Cancer Undergoing Treatment (2016) (0)
QOLP-04. CALCULATING THE NET CLINICAL BENEFIT IN BRAIN TUMOR TRIALS BY COMBINING SURVIVAL AND HEALTH-RELATED QUALITY OF LIFE DATA USING TWO METHODS: QUALITY ADJUSTED SURVIVAL EFFECT SIZES AND JOINT MODELLING (2019) (0)
Patient and Provider Perceptions of Real-Time Quality of Life Measures During Head and Neck Radiation Therapy (2017) (0)
QOL SOS : Quality of life state of the science: An editorial series (2005) (0)
The relationship between cancer patient treatment decision-making roles and quality of life (QOL). (2006) (0)
Lessons learned from implementing the first Alliance NCORP Research Base Cancer Care Delivery Research (CCDR) trial A191402CD. (2018) (0)
A Personalized Decision Aid to Help Women with Lupus Nephritis from Racially and Ethnically Diverse Backgrounds Make Decisions about Taking Immune-Blocking Medicines (2019) (0)
Patient-reported fatigue and overall survival in locally advanced esophageal cancer: A Mayo Clinic Esophageal Adenocarcinoma and Barrett's Esophagus Registry Consortium study. (2011) (0)
Quality of life analysis of NCCTG N0877 (Alliance): Phase II trial of either dasatinib or placebo combined with standard chemoradiotherapy for newly diagnosed glioblastoma multiforme (GBM). (2015) (0)
Linking clinical significance to a sleep intervention model (2003) (0)
Discontinuing chronic medications: Perceptions of patients with life-limiting illness. (2014) (0)
Geriatric and non-geriatric cancer caregivers: Perceived benefits of technology (2014) (0)
Combining efficacy and toxicity effect sizes from randomized clinical trials (RCTs) into an interpretable quality-adjusted effect size estimate in patients with Multiple Myeloma (MM) (2015) (0)
A pooled analysis to estimate the prevalence of sleep complaints among cancer patients (2005) (0)
Assessing simple measures of patient-reported (PR) fatigue for oncology clinical trials: A pooled analysis of 3,915 patients. (2009) (0)
Multi-Dimensional Prognostic Factors for Lung Cancer (2006) (0)
Paroxetine reduced the frequency and severity of hot flushes in some postmenopausal women (2004) (0)
The association of patient fatigue and outcomes in advanced cancer: An analysis of four SWOG treatment trials. (2020) (0)
Maltese Perspectives on Breaking Bad News in Cancer: An Assessment of Patients’ Preferences (2022) (0)
Patient-Reported Outcome Driven Case Management System for Hematology — a Prospective Study (2018) (0)
Repeated Measure Analysis of Dermatitis Symptoms Evolution and Patient-Reported Outcome in N06C4: A Phase 3 Randomized Trial of Mometasone Furoate in Breast Cancer Patients Receiving Radiation Therapy (2013) (0)
A pooled analysis of demographic characteristics and clinical outcomes of phase I oncology clinical trials, the Mayo Clinic experience (2004) (0)
Real-Time Electronic Patient-Reported Outcomes in Relation to Provider-Documented Adverse Events During Radiation Therapy for Head and Neck Cancer (2016) (0)
Correction to: Establishing a common metric for patient-reported outcomes in cancer patients: linking patient reported outcomes measurement information system (PROMIS), numerical rating scale, and patient-reported outcomes version of the common terminology criteria for adverse events (PRO-CTCAE) (2021) (0)
Combining efficacy and toxicity effect sizes from randomized clinical trials (RCTs) into an interpretable quality-adjusted effect size estimate in patients with multiple myeloma (MM). (2015) (0)
Quality‐of‐life Measures, Clinical Significance of (2006) (0)
Relationship of initial quality-of-life deficit and survival in esophageal cancer (EC): The Mayo Clinic Romero Registry experience. (2014) (0)
Feasibility of a patient-reported outcomes quality-of-life instrument to improve care in underserved, ethnic minority patients with cancer. (2018) (0)
Patient-reported outcomes in randomized clinical trials: development of ISOQOL reporting standards Michael BrundageJane BlazebyDennis RevickiBrenda BassHenrica de Vet • Helen DuffyFabio EfficaceMadeleine KingCindy L. K. LamDavid Moher • Jane ScottJeff SloanClaire SnyderSusan YountMelanie Calvert (2013) (0)
QOL concerns in surgical patients: assessment and intervention. (2014) (0)
PCN109 DEVELOPMENT OF THE PATIENT-REPORTED VERSION OF THE COMMON TERMINOLOGY CRITERIA FOR ADVERSE EVENTS (PRO-CTCAE) (2010) (0)
Correlating Patient-Reported Outcomes and Provider-Documented Adverse Events During Radiation Therapy for Head and Neck Cancer (2016) (0)
A population-based study on the quality of life for cancer patients as reported in a tumor registry follow-up. (2006) (0)
High-quality basic care and support needed in lung cancer survivors. (2012) (0)
Burnout and Career Satisfaction Among Men and Women Young Academic Surgeons (2014) (0)
Association between lung cancer survival and pessimistic explanatory style. (2009) (0)
Biologic pathways, candidate genes, and molecular markers associated with quality-of-life domains. (2014) (0)
QOL SOS: Quality of Life State of the Science (2005) (0)
729. Phase I Trial of Intraperitoneal (IP) Administration of a Measles Virus (MV) Strain Expressing the Human Carcinoembryonic Antigen (CEA) in Ovarian Cancer Patients (2006) (0)
A feasibility study of virtual group therapy to improve quality of life of cancer caregivers (2021) (0)
WE-G-9A-01: Radiation Oncology Outcomes Informatics. (2014) (0)
Changes in Quality of Life over Time in Patients Registered on the Mayo Clinic Esophageal Adenocarcinoma and Barrettʼs Esophagus Registry: 71 (2007) (0)
Incorporating Validated Measures for Patient-reported Outcomes in Clinical Practice (2014) (0)
Longitudinal assessment of cognitive impairment among lung cancer survivors. (2009) (0)
Patient-Reported Distress Is Associated With Decreased Survival in Cancer Patients Treated With Definitive Radiation Therapy (2016) (0)
A longitudinal study of alterations in cognitive function and brain metabolites among women receiving chemotherapy for primary breast cancer. (2011) (0)
Prospective NCCTG quality of life (QOL) study in adult newly diagnosed high-grade gliomas (HGG). (2004) (0)
Abstract 801: Frailty and Health Status in Patients With Coronary Disease (2009) (0)
Quality of life assessment of patients participating in phase I clinical trials during treatment (MC0115) (2008) (0)
Comparison of baseline quality of life between minority and non-minority patients participating in oncology clinical trials. (2006) (0)
In Reply: Drs Patterson and Yealy raise questions about the psychometric properties of the assessments (2010) (0)
Decision aids for localized prostate cancer: Initial outcomes from NCI Community Oncology Research Program Alliance Research Base Cancer Care Delivery Research (CCDR) Protocol - A191402CD - A Cluster-Randomized Trial. (2020) (0)
Perceived Quality of Life Among Smokers in Smoking Cessation Therapy. (2005) (0)
A phase III randomized, double-blind placebo controlled study of armodafinil (Nuvigil) to reduce cancer-related fatigue in patients with high-grade glioma (Alliance A221101). (2020) (0)
MODELING ACCRUAL OF OLDER ADULTS TO CANCER CLINICAL TRIALS: (ALLIANCE A151736) (2019) (0)
Patient reported outcomes after splenectomy in patients with symptomatic splenomegaly (2015) (0)
The value of preliminary data in power specifications based upon 64 NCCTG phase II/III treatment trials (2008) (0)
Patient preference for receiving information about long-term symptoms. (2017) (0)
Initial Quality of Life (QOL) Deficit Is Related to Decreased Survival in Esophageal Cancer (EC): Final Report of 840 Consecutive Patients Prospectively Evaluated by the Single-Institutional Romero Registry (2014) (0)
Abstract A42: A nurse practitioner-directed palliative care intervention trial in racially diverse patients with metastatic cancer. (2012) (0)
Baseline Patient-Reported Quality of Life Is Not Related to Overall Survival in Patients Receiving Stereotactic Body Radiation Therapy for Thoracic Malignancies: A Preliminary Report : Outcomes/Health Services Research (2014) (0)
Electronic Patient Reported-Outcomes and Toxicities During Radiation Therapy for Head and Neck Cancer (2015) (0)
Information Needs for Cancer Patients Questionnaire (2017) (0)
PCN457 THE SISAQOL INITIATIVE: ESTABLISHING INTERNATIONAL STANDARDS AND RECOMMENDATIONS FOR THE ANALYSIS OF PATIENT-REPORTED OUTCOMES AND QUALITY OF LIFE DATA IN ONCOLOGY RANDOMIZED CLINICAL TRIALS (2019) (0)
Beliefs, Attitudes and Utilization of Complementary and Alternative Medicine (CAM) among Long-Term Lymphoma Survivors: A Pilot Study. (2005) (0)
Preemptive versus reactive topical clobetasol for regorafenib-induced hand-foot reactions: Results from the ReDOS trial. (2019) (0)
Reply to A. Chan et al (2011) (0)
433 VETERANS WITH TOTAL KNEE ARTHROPLASTY (TKA) OR TOTAL HIP ARTHROPLASTY (THA) HAVE POORER PHYSICAL HEALTH RELATED QUALITY OF LIFE (HRQOL) THAN CONTROLS (2007) (0)
Baseline Patient-Reported Quality-of-Life Is Not Related to Overall Survival in Patients Receiving Stereotactic Body Radiation Therapy for Thoracic Malignancies: A Preliminary Report (2014) (0)
Does participating in clinical trials change the experience of dying for patients with cancer (2005) (0)
Seven-year quality of life assessment in lung cancer (2008) (0)
Outcomes of a Dignity Therapy/Life Plan intervention for advanced cancer patients undergoing treatment. (2017) (0)
Beyond maximum grade: A novel method to assess toxicity over time in clinical trials of targeted therapy in lymphoma. (2016) (0)
University of Birmingham Moving forward toward standardizing analysis of quality of life data in randomized cancer clinical trials (2018) (0)
Phlebotomy vs. Myelosuppressive Medications in Controlling Erythrocytosis in Polycythemia Vera (PV) Patients: Impact upon Fatigue in a Survey of 405 PV Patients. (2006) (0)
Tu1515 Promis for Laparoscopy (2013) (0)
Calibrating clinically significant effects in survival and response endpoints in cancer clinical trials. (2011) (0)
The role of glutathione-related genes in lung cancer survival (1999) (0)
Phenotypic Differences amongst Subgroups of Patients with Myelofibrosis with Myeloid Metaplasia (MMM): Analysis of 458 MMM Patients. (2006) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Jeffrey A. Sloan?

Jeffrey A. Sloan is affiliated with the following schools:

Iowa State University
University of Manitoba
University of Utah

Jeffrey A. Sloan's Academic­Influence.com Rankings